The recent outbreak of coronavirus disease 2019 (COVID‐19), caused by the Severe Acute
Respiratory Syndrome Coronavirus‐2 (SARS‐CoV‐2) has resulted in a world‐wide …

Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) causes a wide spectrum of
clinical manifestations, with progression to multiorgan failure in the most severe cases …

In patients with severe COVID‐19, acute respiratory distress syndrome (ARDS), multiple
organ dysfunction syndrome (MODS), and even mortality can result from cytokine storm …

The aim of this document is to provide a concise scientific review of the currently available
COVID‐19 vaccines and those in development, including mRNA, adenoviral vectors, and …

Curcumin is proposed as a potential treatment option for coronavirus disease‐19 (COVID‐
19) by inhibiting the virus entrance, encapsulation and replication, and modulating various …

Introduction and objectives The coronavirus disease 2019 (COVID-19) pandemic has been
a challenge globally. In severe acute respiratory syndrome (SARS) epidemic 60% of …

Occurrence of hyperglycemia upon infection is associated with worse clinical outcome in
COVID-19 patients. However, it is still unknown whether SARS-CoV-2 directly triggers …

Infection with the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), a novel
coronavirus that emerged in late 2019, is posing an unprecedented challenge to global …

The coronavirus pandemic emerged in early 2020 and turned out to be deadly, killing a vast
number of people all around the world. Fortunately, vaccines have been discovered, and …

COVID-19, a respiratory viral infection, has affected 388 million individuals worldwide as of
the February 4, 2022. In this review, we have outlined the important liver manifestations of …